We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanders Targets Florida Drugmaker over Drug’s ‘Staggering’ List Price
Sanders Targets Florida Drugmaker over Drug’s ‘Staggering’ List Price
Sen. Bernie Sanders (I-Vt.) took aim at Florida-based drug developer Catalyst Pharmaceutical over what he called the “staggering” list price for Firdapse (amifampridine), a treatment for a rare neuromuscular disease that the company plans to launch in the first quarter of 2019.